Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Titel:
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Auteur:
Fizazi, Karim Tran, NamPhuong Fein, Luis Matsubara, Nobuaki Rodriguez-Antolin, Alfredo Alekseev, Boris Y Özgüroğlu, Mustafa Ye, Dingwei Feyerabend, Susan Protheroe, Andrew Sulur, Giri Luna, Yesenia Li, Susan Mundle, Suneel Chi, Kim N